State Street’s Myovant Sciences Ltd. MYOV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-2,910,023
| Closed | -$78.5M | – | 4868 |
|
|
2022
Q4 | $78.5M | Buy |
2,910,023
+893,665
| +44% | +$23.5M | ﹤0.01% | 1337 |
|
|
2022
Q3 | $36.2M | Sell |
2,016,358
-214,996
| -10% | -$3.43M | ﹤0.01% | 1824 |
|
|
2022
Q2 | $27.7M | Sell |
2,231,354
-1,103,581
| -33% | -$12.2M | ﹤0.01% | 2014 |
|
|
2022
Q1 | $44.4M | Buy |
3,334,935
+464,627
| +16% | +$6.23M | ﹤0.01% | 1840 |
|
|
2021
Q4 | $44.7M | Buy |
2,870,308
+584,449
| +26% | +$11.2M | ﹤0.01% | 1887 |
|
|
2021
Q3 | $51.3M | Sell |
2,285,859
-8,958
| -0.4% | -$197K | ﹤0.01% | 1794 |
|
|
2021
Q2 | $52.3M | Buy |
2,294,817
+2,109,302
| +1,137% | +$44.4M | ﹤0.01% | 1812 |
|
|
2021
Q1 | $3.82M | Buy |
185,515
+90,461
| +95% | +$2.06M | ﹤0.01% | 3167 |
|
|
2020
Q4 | $2.63M | Buy |
95,054
+5,760
| +6% | +$112K | ﹤0.01% | 3256 |
|
|
2020
Q3 | $1.25M | Buy |
89,294
+6,151
| +7% | +$114K | ﹤0.01% | 3371 |
|
|
2020
Q2 | $1.71M | Sell |
83,143
-2,932
| -3% | -$39.9K | ﹤0.01% | 3240 |
|
|
2020
Q1 | $650K | Buy |
86,075
+19,119
| +29% | +$214K | ﹤0.01% | 3397 |
|
|
2019
Q4 | $1.04M | Buy |
66,956
+9,456
| +16% | +$95.3K | ﹤0.01% | 3398 |
|
|
2019
Q3 | $299K | Buy |
57,500
+23,800
| +71% | +$177K | ﹤0.01% | 3566 |
|
|
2019
Q2 | $305K | Buy |
33,700
+19,400
| +136% | +$289K | ﹤0.01% | 3569 |
|
|
2019
Q1 | $341K | Hold |
14,300
| – | – | ﹤0.01% | 3503 |
|
|
2018
Q4 | $235K | Sell |
14,300
-32,478
| -69% | -$640K | ﹤0.01% | 3549 |
|
|
2018
Q3 | $1.24M | Hold |
46,778
| – | – | ﹤0.01% | 3369 |
|
|
2018
Q2 | $1.07M | Sell |
46,778
-200
| -0.4% | -$4.37K | ﹤0.01% | 3395 |
|
|
2018
Q1 | $1M | Buy |
46,978
+3,400
| +8% | +$51.8K | ﹤0.01% | 3339 |
|
|
2017
Q4 | $550K | Buy |
43,578
+16,874
| +63% | +$226K | ﹤0.01% | 3437 |
|
|
2017
Q3 | $413K | Hold |
26,704
| – | – | ﹤0.01% | 3505 |
|
|
2017
Q2 | $312K | Sell |
26,704
-111,348
| -81% | -$1.38M | ﹤0.01% | 3492 |
|
|
2017
Q1 | $1.62M | Buy |
138,052
+35,468
| +35% | +$407K | ﹤0.01% | 3155 |
|
|
2016
Q4 | $1.27M | Buy |
+102,584
| New | +$1.19M | ﹤0.01% | 3230 |
|
Other funds holding MYOV
State Street's MYOV Position: Q1 2023 in Review
State Street sold out of Myovant Sciences Ltd. (MYOV) in Q1 2023, closing a stake of 2,910,023 shares — an estimated $78.5M sold.
State Street first reported a position in MYOV in Q4 2016 and held it in 25 quarters. The position peaked at $78.5M in Q4 2022. 2 funds tracked by Wall St. Rank hold MYOV as of Q1 2023.
- State Street reported no remaining Myovant Sciences Ltd. position as of Q1 2023 after selling out during the quarter.
- State Street sold 2,910,023 Myovant Sciences Ltd. shares in Q1 2023, an estimated $78.5M.
- State Street first reported a position in Myovant Sciences Ltd. in Q4 2016 and held it in 25 quarters.
- State Street's Myovant Sciences Ltd. position peaked at $78.5M in Q4 2022.
- 2 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2023.
Based on State Street's 13F filing for Q1 2023, filed 15 May 2023.